© 2019 Smart + Strong. All Rights Reserved. Terms of use and Your privacy. Smart + Strong® is a registered trademark of CDM Publishing, LLC.
Calling all U.S. cisgender gay and bi men and trans and gender nonconforming people at risk for the virus.
Experts discuss rapid changes in cancer treatment and in the management of infections that can accompany these therapies.
One hundred twenty volunteers to enroll in Seattle-area study of cancer-related gene mutations
Ten HIV-positive cancer patients to receive donated cord blood with rare resistance gene.
Checkpoint inhibitor study suggests new treatment options for patients long excluded from cancer immunotherapy clinical trials.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.
